Atrial natriuretic factor as marker of myocardial compromise in Chagas' disease
Authors:
- Jorge ScaglioneJSJorge Scaglione
- Sergio AugerSASergio Auger
- Susana CavalleroSCSusana Cavallero
- Adriana S DonosoADAdriana S Donoso
- Horacio A DupuyHDHoracio A Dupuy
- Belisario E FernándezBFBelisario E Fernández
- 1 May 2002
- journal article
- Published by Elsevier in Regulatory Peptides
- Vol. 105 (2) , 139-143
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular DysfunctionCirculation, 1999
- Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial InfarctionCirculation, 1996
- Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunctionThe American Journal of Cardiology, 1996
- Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitroCell, 1993
- Natriuretic peptide system in human heart failure.Circulation, 1993
- Endothelin: A Potent Stimulus of Atrial Natriuretic Peptide Secretion by Superfused Rat Atria and Its Dependency on Calcium*Endocrinology, 1990
- Diverse biological actions of atrial natriuretic peptidePhysiological Reviews, 1990
- A new natriuretic peptide in porcine brainNature, 1988
- The Heart and the Atrial Natriuretic Factor*Endocrine Reviews, 1985
- A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in ratsLife Sciences, 1981